Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | Mkt Perform → Underperform | Raymond James | |
| 4/3/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 11/11/2024 | $18.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2023 | $21.00 | Neutral | Janney |
| 8/10/2021 | $23.00 → $26.00 | Neutral → Overweight | Piper Sandler |
DALLAS, Dec. 5, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE:NREF) (the "Company") today announced a dividend for its 8.50% Series A Cumulative Redeemable Preferred Stock (NYSE:NREF) of $0.53125 per share. The dividend will be payable on January 26, 2026, to stockholders of record at the close of business on January 15, 2026. About NexPoint Real Estate Finance, Inc. NexPoint Real Estate Finance, Inc., is a publicly traded REIT, with its common stock and Series A Preferred Stock listed on the New York Stock Exchange under the symbol "NREF" and "NREF PRA," re
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $1.4 million, or $0.03 per diluted share, and operating income(1) of $7.9 million, or $0.15 per diluted share, for the three months ended September 30, 2025. For the nine months ended September 30, 2025, net income was $17.5 million, or $0.34 per diluted share, and operating income was $41.5 million, or $0.80 per diluted share. Third Quarter Highlights(2) Operating performance continues to demonstrate progress toward premium rate levels appropriate for the challenging conditions in the medical professional liability and worker
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0.65 per diluted share. Second Quarter Highlights(2) Second-quarter operating performance continues to demonstrate our continued progress toward premium rate levels appropriate for the challenging conditions in the medical profession
Raymond James downgraded ProAssurance from Mkt Perform to Underperform
Citizens JMP downgraded ProAssurance from Mkt Outperform to Mkt Perform
Piper Sandler downgraded ProAssurance from Overweight to Neutral and set a new price target of $18.00
4 - PROASSURANCE CORP (0001127703) (Issuer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
8-K - PROASSURANCE CORP (0001127703) (Filer)
SCHEDULE 13G - PROASSURANCE CORP (0001127703) (Subject)
10-Q - PROASSURANCE CORP (0001127703) (Filer)
SC 13G/A - PROASSURANCE CORP (0001127703) (Subject)
SC 13G - PROASSURANCE CORP (0001127703) (Subject)
SC 13G - PROASSURANCE CORP (0001127703) (Subject)
PICA Group, part of the ProAssurance family of companies, announced today the retirement of Dr. Ross E. Taubman, DPM. effective March 31, 2024, after 12 years of dedicated service. During his tenure, Dr. Taubman has been a valuable leader of the PICA Group team, overseeing PICA and OUM since he joined the company in 2011, as well as assuming responsibility as the head of PICA Group's additional business units, DentistCare and LawyerCare, in 2019. Throughout his time as President, Dr. Taubman demonstrated exceptional strategic vision and a passion for innovation. His commitment has helped PICA Group expand its market presence and deliver exceptional results. Under his guidance, PICA has
BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Board of Directors of ProAssurance Corporation (NYSE:PRA) has declared a cash dividend of $0.05 per common share, payable on January 7, 2021 to shareholders who own our stock as of December 22, 2020. For 2020, our dividend policy anticipates a total annual dividend of $0.72 per share. On an annualized basis going forward, our policy anticipates annual dividends of $0.20 per share to be paid in equal quarterly installments. However, any decision to pay future cash dividends will be subject to the Board’s final determination after a comprehensive review of the company’s financial performance, future expectations, and other factors deemed relev
DALLAS, Dec. 5, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE:NREF) (the "Company") today announced a dividend for its 8.50% Series A Cumulative Redeemable Preferred Stock (NYSE:NREF) of $0.53125 per share. The dividend will be payable on January 26, 2026, to stockholders of record at the close of business on January 15, 2026. About NexPoint Real Estate Finance, Inc. NexPoint Real Estate Finance, Inc., is a publicly traded REIT, with its common stock and Series A Preferred Stock listed on the New York Stock Exchange under the symbol "NREF" and "NREF PRA," re
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $1.4 million, or $0.03 per diluted share, and operating income(1) of $7.9 million, or $0.15 per diluted share, for the three months ended September 30, 2025. For the nine months ended September 30, 2025, net income was $17.5 million, or $0.34 per diluted share, and operating income was $41.5 million, or $0.80 per diluted share. Third Quarter Highlights(2) Operating performance continues to demonstrate progress toward premium rate levels appropriate for the challenging conditions in the medical professional liability and worker
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0.65 per diluted share. Second Quarter Highlights(2) Second-quarter operating performance continues to demonstrate our continued progress toward premium rate levels appropriate for the challenging conditions in the medical profession